Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy
Immunotherapy in colorectal cancer (CRC) regulates specific immune checkpoints and, when used in combination with chemotherapy, can improve patient prognosis. One specific immune checkpoint is the recruitment ...
Source: BMC Immunology - Category: Allergy & Immunology Authors: Shelby N. Bess, Gage J. Greening, Narasimhan Rajaram and Timothy J. Muldoon Tags: Research Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colon Cancer | Colorectal Cancer | Immunotherapy